Somaxon Pharmaceuticals, Inc.
SOMX, a specialty pharmaceutical company, today announced that its
Board of Directors approved a 1-for-8 reverse stock split of its common stock
and a decrease in the number of authorized shares of its common stock from
100,000,000 to 25,000,000 shares. The reverse stock split and the decrease in
the number of authorized shares of common stock were authorized by Somaxon's
stockholders at a special meeting held on October 5, 2012. The reverse stock
split will become effective as of 5:00 p.m. Pacific Time on October 11, 2012
and Somaxon's shares will trade on a post-split basis beginning on October 12,
2012. The new CUSIP number for Somaxon's common stock will be 834453 201.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Posted In: NewsStock Split
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in